NEW YORK (GenomeWeb) – Waters today reported that its revenues in the third quarter were up 2 percent year over year, with the strongest sales coming from the company's Asia-Pacific and academic and government customers.

The company posted revenues of $578 million, up from $565.6 million in Q3 2017, but falling short of the average Wall Street estimate of $587.8 million. Waters said that foreign currency translation decreased sales growth by around 1 percent in the quarter.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Germany's Project DEAL has come to an agreement with the publisher Wiley over journal access and open-access publishing, ScienceInsider reports.

Researchers uncover additional loci associated with lifespan, which the Telegraph says could be folded into a genetic test.

A Canadian panel recommends public coverage of the gene therapy Kymriah if its cost comes down, the Globe and Mail reports.

In Nucleic Acids Research this week: new accurate quantification by sequencing approach, CNV breakpoints in Plasmodium falciparum, and more.

Feb
21
Sponsored by
L7 Informatics

This webinar will provide a first-hand look at how Gradalis, a clinical-stage immunotherapy developer, is using an information management solution from L7 to streamline its research, clinical, and manufacturing operations.